LB Pharmaceuticals Company
LB is focused on the multi-billion dollar US antipsychotic market and is developing a proprietary.
Technology:
Metabolic Disorders
Industry:
PharmTech
Headquarters:
New York, New York, United States
Founded Date:
2015
Employees Number:
11-50
Funding Status:
Early Stage Venture
Estimated Revenue:
$1M to $10M
Register and Claim Ownership